BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30647455)

  • 1. Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumab.
    Wang D; Xu Q; Yuan Q; Jia M; Niu H; Liu X; Zhang J; Young CY; Yuan H
    Oncogene; 2019 May; 38(18):3458-3474. PubMed ID: 30647455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between HSPA5 arginylation and sequential ubiquitination leads to AKT degradation through autophagy flux.
    Kim HJ; Kim SY; Kim DH; Park JS; Jeong SH; Choi YW; Kim CH
    Autophagy; 2021 Apr; 17(4):961-979. PubMed ID: 32164484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-metastatic activity of AGR2 interrupts angiogenesis target bevacizumab efficiency via direct interaction with VEGFA and activation of NF-κB pathway.
    Jia M; Guo Y; Zhu D; Zhang N; Li L; Jiang J; Dong Y; Xu Q; Zhang X; Wang M; Yu H; Wang F; Tian K; Zhang J; Young CYF; Lou H; Yuan H
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1622-1633. PubMed ID: 29410027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous inhibition of the ubiquitin-proteasome system and autophagy enhances apoptosis induced by ER stress aggravators in human pancreatic cancer cells.
    Li X; Zhu F; Jiang J; Sun C; Zhong Q; Shen M; Wang X; Tian R; Shi C; Xu M; Peng F; Guo X; Hu J; Ye D; Wang M; Qin R
    Autophagy; 2016 Sep; 12(9):1521-37. PubMed ID: 27308733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apigenin manipulates the ubiquitin-proteasome system to rescue estrogen receptor-β from degradation and induce apoptosis in prostate cancer cells.
    Singh V; Sharma V; Verma V; Pandey D; Yadav SK; Maikhuri JP; Gupta G
    Eur J Nutr; 2015 Dec; 54(8):1255-67. PubMed ID: 25408199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid induction of p62 and GABARAPL1 upon proteasome inhibition promotes survival before autophagy activation.
    Sha Z; Schnell HM; Ruoff K; Goldberg A
    J Cell Biol; 2018 May; 217(5):1757-1776. PubMed ID: 29535191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of proteasome reveals basal mitochondrial ubiquitination.
    Sulkshane P; Duek I; Ram J; Thakur A; Reis N; Ziv T; Glickman MH
    J Proteomics; 2020 Oct; 229():103949. PubMed ID: 32882436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin ligase SYVN1/HRD1 facilitates degradation of the SERPINA1 Z variant/α-1-antitrypsin Z variant via SQSTM1/p62-dependent selective autophagy.
    Feng L; Zhang J; Zhu N; Ding Q; Zhang X; Yu J; Qiang W; Zhang Z; Ma Y; Huang D; Shen Y; Fang S; Yu Y; Wang H; Shen Y
    Autophagy; 2017 Apr; 13(4):686-702. PubMed ID: 28121484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of proteasome-ubiquitin protein degradation in autophagy and the activation of AMP-activated protein kinase.
    Jiang S; Park DW; Gao Y; Ravi S; Darley-Usmar V; Abraham E; Zmijewski JW
    Cell Signal; 2015 Jun; 27(6):1186-97. PubMed ID: 25728513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome inhibition promotes Parkin-Ubc13 interaction and lysine 63-linked ubiquitination.
    Lim GG; Chew KC; Ng XH; Henry-Basil A; Sim RW; Tan JM; Chai C; Lim KL
    PLoS One; 2013; 8(9):e73235. PubMed ID: 24023840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.
    Milan E; Perini T; Resnati M; Orfanelli U; Oliva L; Raimondi A; Cascio P; Bachi A; Marcatti M; Ciceri F; Cenci S
    Autophagy; 2015; 11(7):1161-78. PubMed ID: 26043024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
    Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
    Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism.
    Modernelli A; Naponelli V; Giovanna Troglio M; Bonacini M; Ramazzina I; Bettuzzi S; Rizzi F
    Sci Rep; 2015 Oct; 5():15270. PubMed ID: 26471237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
    Rui YN; Xu Z; Chen Z; Zhang S
    Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome Inhibitors Bortezomib and Carfilzomib Stimulate the Transport Activity of Human Organic Anion Transporter 1.
    Fan Y; You G
    Mol Pharmacol; 2020 Jun; 97(6):384-391. PubMed ID: 32234809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the ubiquitin-proteasome system and autophagy in regulation of insulin sensitivity in serum-starved 3T3-L1 adipocytes.
    Zhang Y; Ye M; Chen LJ; Li M; Tang Z; Wang C
    Endocr J; 2015; 62(8):673-86. PubMed ID: 25959705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytotoxic concentration of rosmarinic acid increases MG132-induced cytotoxicity, proteasome inhibition, autophagy, cellular stresses, and apoptosis in HepG2 cells.
    Ozgun GS; Ozgun E
    Hum Exp Toxicol; 2020 Apr; 39(4):514-523. PubMed ID: 31876192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer.
    Wu YH; Hong CW; Wang YC; Huang WJ; Yeh YL; Wang BJ; Wang YJ; Chiu HW
    Cancer Lett; 2017 Aug; 400():79-88. PubMed ID: 28450160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ErbB2 trafficking and degradation associated with K48 and K63 polyubiquitination.
    Marx C; Held JM; Gibson BW; Benz CC
    Cancer Res; 2010 May; 70(9):3709-17. PubMed ID: 20406983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAG3 induction is required to mitigate proteotoxicity via selective autophagy following inhibition of constitutive protein degradation pathways.
    Rapino F; Jung M; Fulda S
    Oncogene; 2014 Mar; 33(13):1713-24. PubMed ID: 23644654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.